Yoshimi A, Cario H, Timmermann K, Kontny U, Lobitz S, Odenthal HS, Schmid I, Seitz B, Höll T, Lücke T, Borkhardt A, Strauß G, Hohnecker A, Metzler M, Karall D, Noellke P, Niemeyer CM, Grünert SC (2026)
Publication Type: Journal article
Publication year: 2026
Book Volume: 148
Article Number: 110160
Journal Issue: 3
DOI: 10.1016/j.ymgme.2026.110160
Background: Pearson syndrome (PS) is a rare, unique primary mitochondrial disorder characterized by single large-scale mitochondrial DNA deletions, bone marrow failure, lactic acidosis, and progressive multi-organ complications. Methods: We retrospectively evaluated anthropometric data from 25 patients with PS. Results: The median height, weight, and body mass index (BMI) standard deviation scores (SDS) at the last measurement were − 1.95 (range: −7.32 to 1.09), −1.70 (range: −12.26 to 0.11), and − 1.52 (range: −5.01 to 2.19), respectively; 50%, 40%, and 37.5% of patients, respectively, had values below −2 SDS. Longitudinal data from 18 patients showed that height and weight SDS declined progressively with age in most patients, whereas BMI SDS fluctuated without a clear age-related trend. Initiation of tube feeding improved weight and BMI SDS in some patients, while height SDS continued to decline without catch-up growth. Patients with organ failure exhibited an earlier decline in height SDS than those without organ failure. Conclusions: Patients with PS are generally short and underweight, and their short stature worsens over time. The presence of organ failure further exacerbates growth impairment.
APA:
Yoshimi, A., Cario, H., Timmermann, K., Kontny, U., Lobitz, S., Odenthal, H.S.,... Grünert, S.C. (2026). Progressive short stature in Pearson syndrome and the impact of organ failure. Molecular Genetics and Metabolism, 148(3). https://doi.org/10.1016/j.ymgme.2026.110160
MLA:
Yoshimi, Ayami, et al. "Progressive short stature in Pearson syndrome and the impact of organ failure." Molecular Genetics and Metabolism 148.3 (2026).
BibTeX: Download